Stockwinners Market Radar for August 17, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:31 EDT Chewy CEO sells $11.26M in common stock - In a regulatory filing, Chewy disclosed that its CEO Sumit Singh sold 228.4K shares of common stock on August 15 in a total transaction size of $11.26M.

20:26 EDT Cathie Wood's ARK Investment bought 1.11M shares of Invitae today

19:03 EDT Newpark Resources director buys $239.5K in common stock - In a regulatory filing, Newpark Resources disclosed that its director Donald Young bought 89.6K shares of common stock on August 15th in a total transaction size of $239.5K.

18:46 EDT NYSE to suspend trading in Eros Media World - NYSE announced that the staff of NYSE Regulation has determined to commence proceedings to delist the A Ordinary Shares of Eros Media World Plc from the NYSE. Trading in the company's A Ordinary Shares will be suspended immediately. NYSE Regulation reached its decision that the company's A Ordinary Shares are not suitable for listing, because the company is a late filer and has not filed with the Securities and Exchange Commission its annual report on Form 20-F for the year ended March 31, 2021, current report on Form 6-K for the half year ended September 30, 2021 and annual report on Form 20-F for the year ended March 31, 2022. The company has a right to a review of this determination by a Committee of the Board of Directors of the Exchange.

17:52 EDT Vertex Pharmaceuticals CEO sells $3.6M in common stock - In a regulatory filing, Vertex Pharmaceuticals disclosed that its CEO Reshma Kewalramani sold 11.7K shares of common stock on August 15th in a total transaction size of $3.6M.

17:49 EDT Plus Therapeutics awarded $17.6M from State of Texas - Plus Therapeutics was awarded a $17.6M Product Development Research grant by the Cancer Prevention and Research Institute of Texas to fund the continued development of the company's lead investigational targeted radiotherapeutic, Rhenium-186 NanoLiposome - 186RNL -, for the treatment of patients with leptomeningeal metastases. In Q2, the company completed enrollment of Cohort 1 in the ReSPECT-LM Phase 1/2a dose escalation trial. 186RNL was delivered without dose limiting toxicities in this initial cohort, and the independent Data and Safety Monitoring Board has approved the plan to move ahead with Cohort 2. The FDA has granted Fast Track designation to 186RNL for the treatment of LM.

17:28 EDT Director of Aehr Test Systems Slayen sells over $182K in shares - Director of Aehr Test Systems Howard Slayen disclosed in a regulatory filing that he had sold 10,000 shares of company stock at $18.26 per share on August 15, for a total transaction amount of $182,557.

17:20 EDT Cineworld evaluates strategic options amid slow attendance, limited film slate - Cineworld Group gave an update on trading, liquidity and capital structure earlier on Wednesday. The company said in part: "Cineworld is providing an update today on its current trading, liquidity position and capital structure and the ongoing impact of the COVID-19 pandemic on the Group. Despite a gradual recovery of demand since re-opening in April 2021, recent admission levels have been below expectations. These lower levels of admissions are due to a limited film slate that is anticipated to continue until November 2022 and are expected to negatively impact trading and the Group's liquidity position in the near term. Consequently, the Group has been taking proactive steps to ensure it has the balance sheet strength and flexibility to adapt to market conditions...In connection with these initiatives, the Group remains in active discussions with various stakeholders and is evaluating various strategic options to both obtain additional liquidity and potentially restructure its balance sheet through a comprehensive deleveraging transaction. Any deleveraging transaction will likely result in very significant dilution of existing equity interests in Cineworld...A further announcement will be made if and when appropriate." Other companies that may be impacted include:EPR Properties (EPR ), Cinemark (CNK), AMC Entertainment (AMC) and Imax (IMAX). Reference Link

17:14 EDT Rolls-Royce awarded $1.01B Navy contract - Rolls-Royce was awarded a $1.01B firm-fixed-price, indefinite-delivery, requirements contract. This contract provides intermediate, depot-level maintenance and related logistics support for approximately 210 in-service T-45 F405-RR-401 Adour engines in support of the Navy. Work is expected to be completed in July 2027. No funds will be obligated at the time of award; funds will be obligated on individual orders as they are issued. This contract was not competitively procured pursuant to Defense Federal Acquisition Regulation 6.302-1. The Naval Air System Command is the contracting activity.

17:05 EDT Phillips 66 increases interest in DCP Midstream from 28.26% to 43.31% - Phillips 66 (PSX) announced a realignment of its economic and governance interests in DCP Midstream (DCP) and Gray Oak Pipeline through the merger of existing joint ventures owned with Enbridge (ENB). Phillips 66 increased its economic interest in DCP Midstream from 28.26% to 43.31% and will oversee and manage the joint venture's interest in DCP Midstream, including the General Partner. Phillips 66's economic interest in Gray Oak Pipeline decreased from 42.25% to 6.50%. Enbridge will oversee and manage the joint venture's interest in Gray Oak Pipeline. As part of the transaction, Phillips 66 contributed approximately $400M of cash. The transaction is expected to be accretive to earnings. Gray Oak Holdings, a joint venture between Phillips 66 and Enbridge, has been merged with and into DCP Midstream, LLC. The joint venture continues to own 65% of the Gray Oak Pipeline crude oil system with capacity of 900K barrels per day of crude oil from the Permian and Eagle Ford basins in West Texas to the U.S. Gulf Coast. The transaction was entered into and closed on August 17.

16:59 EDT Meme stocks slip afterhours as Ryan Cohen files intent to cash out of BBBY - Shares of Bed Bath & Beyond (BBBY) are down 18% afterhours below $19 as investor Ryan Cohen submitted a filing with the SEC detailing his intention to liquidate his entire 11.8% stake in the company. Shares of other high-short-interest "meme" names are also trading lower - GameStop (GME) is down 4.3%, Blue Apron (APRN) is down 6.9%, and FuboTV (FUBO) is down 4.9% at the time of writing.

16:56 EDT Hyzon Motors receives late filing notice from Nasdaq - Hyzon Motors has received a notice from Nasdaq stating that because the company has not yet filed its Q2 report on Form 10-Q for the quarter ended June 30, the company is no longer in compliance with the Nasdaq listing rule which requires listed companies to timely file all required periodic reports with the SEC. The notification letter has no immediate effect on the listing or trading of the company's common stock on the Nasdaq Global Select Market. Nasdaq indicated that the company must submit a plan within 60 calendar days from August 16, or no later than October 14, addressing how it intends to regain compliance with Nasdaq's listing rules. If Nasdaq accepts the Company's plan, it may grant the company an extension of up to until February 13, 2023, to regain compliance. The company's management is working diligently to complete the Form 10-Q and intends to file the Form 10-Q as soon as practicable, but does not expect to do so within the timeframe specified by Rule 12b-25 for the reasons discussed in the notification.

16:46 EDT Cisco says cancellations below pre-pandemic levels - Says growth will be dependent on component availability. Says supply constraints started to ease slightly in Q4. Comments taken from Q4 earnings conference call.

16:33 EDT VP of Insperity Herink sells $575.5K in company shares - VP of Insperity Daniel Herink disclosed in a filing that he had sold 5,000 shares of company stock at $115.10 per share on August 15, for a total transaction amount of $575,500.

16:31 EDT American Financial Group raises annual dividend 12.5% to $2.52 from $2.24 - American Financial Group announced that its Board of Directors has approved an increase in the company's regular annual dividend to $2.52 from $2.24 per share of common stock. The increased dividend, when declared, will be paid on a quarterly basis of 63c per share of common stock beginning in October. The new dividend rate represents a 12.5% increase over the annual rate paid thus far in 2022. The company has increased its dividend in each of the last seventeen years.

16:30 EDT Perrigo issues statement on market trading activity - Perrigo issued a statement In response to speculative commentary regarding ranitidine - Zantac - litigation from a news story that the company claims contained certain misleading and inaccurate information: "on August 4, Perrigo was dismissed from the Madison County, IL, case of Bayer v. Boehringer Ingelheim, with prejudice, meaning the plaintiff's claims against Perrigo in that litigation cannot be refiled. The August 16, 2022 notice of dismissal of claims, and impending trial, against the branded companies did not involve Perrigo. Contrary to the news story, plaintiff's filings contradict the false report that the plaintiff only purchased private label product. In fact, plaintiff's complaint claimed purchases of both brand name Zantac and private label ranitidine. Importantly, there have been no material developments regarding ranitidine-related litigation to what has been previously disclosed. The industry maintains strong defenses to such claims based on the body of scientific evidence, which indicates there is no causal relationship between ranitidine and cancer. Further, as a private label manufacturer, Perrigo has additional defenses under federal preemption. These defenses have been successfully used to obtain dismissals in the majority of ranitidine cases involving Perrigo. To date, Perrigo has successfully won multiple Motions to Dismiss in the federal multi-district litigation and state court actions in California and Maryland. Perrigo will continue to vigorously defend itself against all meritless claims".

16:25 EDT Bath & Body Works saw declines in traffic trends in June, first part of July - Sales trends improved in the latter half of July, the company said, but traffic trends remained below first quarter trends.

16:24 EDT Bath & Body Works recently cut 130 roles in home office organization - Bath & Body Works, in its Q2 earnings commentary, said the company is starting the fall season with "clean and forward-facing inventory." The company said it has re-examined the business and identified areas for improvement in its store operating model and associated labor hours, home office organizational structure and direct fulfillment network. It recently took actions to simplify and realign its leadership and operating structure in home office organization, including shifting areas of responsibility and organizing our merchandise, marketing, planning and channel teams as omni and customer-first teams, and cut about 130 roles, the majority of which were leadership positions. Bath & Body Works sees a benefit of approximately $15M in Q3 and an estimated benefit of approximately $30M in 2H.

16:17 EDT Cue Health's POC COVID-19 test as accurate as lab-based PCR test in study - Cue Health announced the preprint publication of an independent clinical study, the largest of its kind on asymptomatic people, demonstrating that its point of care molecular COVID-19 test, which produces results in approximately 20 minutes, is as accurate as a centralized lab-based RT-PCR. The study presents findings from a head-to-head comparison of the Cue COVID-19 test against lab-based RT-PCR on paired samples from 3,037 individuals. The findings revealed a 99.4% match between results from Cue's test and the reference PCR tests, including 100% clinical sensitivity to detect positive cases, yielding no false negatives. Of this testing population, 98.7% was asymptomatic at varying stages of infection and viral load.

16:15 EDT Grove changes name to Upexi, ticker to UPXI - Grove announced that August 17, its trading name on the Nasdaq officially changed from "Grove Inc." to "Upexi, Inc." and its ticker symbol changed from "GRVI" to "UPXI". No action is required by the company's current shareholders as a result of this change, and the change in its ticker symbol will have no effect on its business goals, strategy, or fees and expenses.

16:12 EDT AeroVironment acquires Planck Aerosystems, terms not stated - AeroVironmen announced it has acquired Planck Aerosystems, a provider of advanced unmanned aircraft navigation solutions. The acquisition will "significantly accelerate AeroVironment's development of advanced autonomy capabilities. Planck's products include embedded technologies and fully integrated unmanned aircraft systems and leverage their deep technical expertise in UAS guidance and navigation, autonomy and artificial intelligence". AeroVironment CEO Wahid Nawabi states: ""Planck has a compelling product and technology roadmap with valuable capabilities that we plan to deploy and integrate with AeroVironment's existing portfolio of intelligent, multi-domain robotic systems. The Planck team has developed advanced unmanned autonomy and navigation solutions for various defense and commercial customers and by working together, we believe we offer more compelling and differentiated solutions to our customers moving forward. This transaction accelerates AeroVironment's innovation in flight autonomy, increasing the effectiveness of our solutions in contested environments and reducing the cognitive load of operators, and adds a tethered SUAS to our portfolio of systems, creating exciting opportunities for upcoming programs of record."

16:10 EDT Eargo supports FDA's OTC hearing aid final ruling - Eargo announced its support of the new regulatory category of over-the-counter hearing aids, as finalized by the Food and Drug Administration Wednesday, August 17. Christian Gormsen, President and Chief Executive Officer, said, "This ruling directly aligns with Eargo's mission. By making hearing aids more accessible and affordable while maintaining safety standards, the industry will now finally be driven by consumer demand for superior products."Gormsen continued, "Based on our initial review of the final rule, we believe Eargos can continue to be sold under existing regulations as well as classified as OTC hearing aids, subject to compliance with labelling and other requirements of the final rule. For example, we believe Eargo hearing aids currently on the market are within the FDA's output and insertion depth limit requirements. We also believe the FDA's removal of certain selling restrictions for OTC hearing aids will allow Eargo to expand the way we serve customers by making the addition of full retail and physical locations in a simplified and scalable way, which will allow Eargo to more broadly meet customers' hearing health needs. We plan on adding partnered physical locations to our online experience in 2022 and 2023. With that said, we will need to expend time and resources evaluating the final rule and ensuring that our devices and processes come into compliance with the new requirements."

16:09 EDT Wolfspeed jumps 12% to $95.59 after above-consensus Q4 earnings and guidance

16:09 EDT InnovAge names Richard Feifer as chief medical officer - InnovAge named Richard Feifer as its chief medical officer, or CMO, effective August 15. As CMO, Feifer will lead InnovAge's clinical care delivery, including medical care, quality, pharmacy, dental, and behavioral health. Most recently, Feifer spent six years at Genesis HealthCare in multiple leadership roles.

14:37 EDT Bluebird Bio confirms Zynteglo wholesale acquisition cost of $2.8M - Following the FDA approval of Zynteglo, also known as beti-cel, for the treatment of beta-thalassemia in adult and pediatric patients who require regular red blood cell transfusions, bluebird bio released details of its U.S. commercial infrastructure to support rapid access to Zynteglo, including what it calls "an innovative, outcomes-based contract offering and a comprehensive patient support program." The company said: "Under the current standard of care, patients with transfusion-dependent beta-thalassemia require RBC transfusions every two to five weeks and may lose decades of life relative to the general population. The lifetime cost of medical care for a patient with transfusion-dependent beta-thalassemia can reach up to $6.4M in the U.S. and the average total health care cost per patient per year is 23 times higher than the general population. bluebird estimates that there are approximately 1,300-1,500 individuals with transfusion-dependent beta-thalassemia in the U.S." bluebird has set the wholesale acquisition cost of Zynteglo in the U.S. at $2.8M, in "recognition of its robust and sustained clinical benefit demonstrated in clinical studies and its potential to alleviate a lifetime of health care costs associated with regular RBC transfusions and iron management." Tom Klima, chief commercial and operating officer of bluebird bio, said: "As the first and only FDA-approved gene therapy for people with beta-thalassemia who require regular red blood cell transfusions, and with the potential to untether patients from a lifelong, burdensome treatment regimen, Zynteglo is setting the standard for what a one-time therapy can deliver. We have developed an equally innovative commercial infrastructure in collaboration with payers and providers, and with a focus on patients, to enable broad and timely access to ZYNTEGLO for eligible patients and to support patients and families at every step of the treatment journey."

14:14 EDT Partner Communications announces receipt of lawsuit filed by Lapidot Capital - Partner Communications reports that on August 17, the company received a lawsuit filed by Lapidot Capital Ltd., which hold 2,173,126 of the company's shares, in the Central District Court in Lod. "The company is reviewing the lawsuit. Due to the preliminary stage of the proceeding, the company is unable to evaluate the probability of success of the lawsuit," Partner stated in a press release.

14:08 EDT Bluebird Bio confirms FDA approval of Zynteglo - bluebird bio announced the U.S. Food and Drug Administration has approved Zynteglo, also known as beti-cel, a one-time gene therapy custom-designed to treat the underlying genetic cause of beta-thalassemia in adult and pediatric patients who require regular red blood cell transfusions. "Due to the complex nature of gene therapy, Zynteglo will be available exclusively at Qualified Treatment Centers, which are carefully selected based on their expertise in relevant areas such as stem cell transplantation, cell and gene therapy, and beta-thalassemia; and receive specialized training to administer Zynteglo. Information on bluebird's QTC network, as well as personalized support focused on the needs of each patient throughout their treatment journey and information on insurance coverage and access will be available through bluebird's patient support program," the company stated. "The FDA approval of Zynteglo offers people with beta-thalassemia the possibility of freedom from burdensome regular red blood cell transfusions and iron chelation, and unlocks new possibilities in their daily lives. After more than a decade of research and clinical development, and through the perseverance of clinicians, patients, and their families, the approval of Zynteglo marks a watershed moment for the field of gene therapy. As the first ex-vivo lentiviral vector gene therapy approved in the U.S. for the treatment of people with beta-thalassemia, we are ushering in a new era in which gene therapy has the potential to transform existing treatment paradigms for diseases that currently carry a lifelong burden of care," said Andrew Obenshain, CEO of bluebird bio. bluebird bio will host a call for analysts and investors on Thursday, August 18, at 8:00 am ET, the company noted.

13:43 EDT FDA approves Zynteglo for those with beta-thalassemia who need transfusions - The U.S. Food and Drug Administration announced it has approved Zynteglo, which it identifies as "the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions." Zynteglo is a one-time gene therapy product administered as a single dose. Each dose of Zynteglo is a customized treatment created using the patient's own cells that are genetically modified to produce functional beta-globin. The FDA granted approval of Zynteglo to bluebird bio. "Today's approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing red blood cell transfusions. Given the potential health complications associated with this serious disease, this action highlights the FDA's continued commitment to supporting development of innovative therapies for patients who have limited treatment options," said Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research.

13:33 EDT Neogen shareholders approval proposals required for 3M food safety combination - Neogen Corporation (NEOG) announced that, at the special meeting of Neogen shareholders, Neogen shareholders voted to approve all proposals required in connection with the pending combination of the food safety business of 3M Company (MMM) with Neogen, including the issuance of shares of Neogen common stock pursuant to the Agreement and Plan of Merger, dated as of December 13, 2021, among Neogen, 3M, Nova RMT Sub, Inc., a wholly owned subsidiary of Neogen, and Garden SpinCo Corporation, currently a wholly owned subsidiary of 3M, and certain amendments to Neogen's organizational documents. The transaction is expected to be completed on September 1, 2022, subject to the satisfaction or waiver of the remaining customary closing conditions. Neogen will file the final voting results, as certified by the independent Inspector of Election, on a Form 8-K with the U.S. Securities and Exchange Commission.

13:23 EDT Denbury jumped 13% to $88.89 after Bloomberg report

13:00 EDT Spotify expanding Samsung partnership with more pre-installs, free trials - Spotify (SPOT) said yesterday in a blog post: "Since 2018, Spotify and Samsung have been a match made in heaven. The partnership between the two has allowed Samsung users to seamlessly connect their devices so that the music never has to stop. Fast-forward to 2022, and we've got more exciting news to share for Samsung users who are looking to play their favorite hits and top podcasts on their devices... When you get a new device, the last thing you want to do is fiddle with an app store in order to dive into your music or podcasts. If you buy a 2022 Samsung Smart TV or Samsung Galaxy smartphone, Spotify will be preloaded globally, making your shift to listening even easier... As Spotify's availability continues to expand, we're offering three free months of Spotify Premium to eligible* Samsung users in 85 markets** around the world. This offer, for those who haven't tried Spotify Premium before, lets new listeners enjoy all the Premium benefits fans have come to love." Reference Link

12:31 EDT Emerald Holding's Elastic Suite announces partnership agreement with AGM - Elastic Suite, a subsidiary of Emerald Holding, announced a major partnership agreement with the Association of Golf Merchandisers. The agreement provides AGM member retailers with access to Elastic's experience in digital merchandising, large network of major global brand partners and the company's expertise for helping retailers benefit from a more strategic and streamlined wholesale purchasing process, the company said in a statement.

12:02 EDT C&F Financial raises quarterly dividend 5% to 42c per share - The board of directors of C&F Financial Corporation has declared a regular cash dividend of 42c per share, which is payable October 1, 2022 to shareholders of record on September 15, 2022. This dividend represents a 5 percent increase over the prior quarter's dividend amount of 40c per share.

12:00 EDT Velo3D falls -14.4% - Velo3D is down -14.4%, or -81c to $4.79.

12:00 EDT Daily S&P Biotech Bear 3x Shares rises 9.6% - Daily S&P Biotech Bear 3x Shares is up 9.6%, or $1.64 to $18.73.

12:00 EDT Direxion Daily Semiconductor Bear 3X Shares rises 11.2% - Direxion Daily Semiconductor Bear 3X Shares is up 11.2%, or $3.88 to $38.50.

11:45 EDT EPR Properties says Regal current on payments, not in negotiations - Cineworld Group (CNNWF), the parent entity of entities that lease EPR Properties' (EPR) Regal theatres, provided an update regarding its current trading, liquidity position and capital structure wherein Cineworld disclosed that it is "evaluating various strategic options to both obtain additional liquidity and potentially restructure its balance sheet through a comprehensive deleveraging transaction," EPR disclosed in a regulatory filing. EPR says it intends to have discussions with investors, analysts and securities advisers in which it may disclose the following information which has not been previously disclosed by EPR Properties: Regal is current on all payments due to EPR Properties as of the filing hereof; EPR Properties is not in current negotiations with Regal or Cineworld regarding their obligations to EPR Properties.

11:36 EDT EPR Properties trading halted, news pending

11:20 EDT TJX expects to repurchase $2.25B-$2.5B of TJX stock this FY

11:17 EDT TJX committed to returning to pre-Covid pretax margin of 10.6% within 3 years

11:08 EDT Airbnb introduces anti-party technology in U.S., Canada - In an announcement yesterday, Airbnb said, "In June, we announced that our previously temporary ban on parties will become a codified policy. We are continuing our work to enforce that policy by taking measures trying to the best of our ability to take on unauthorized parties - meaning parties thrown without the knowledge or consent of Hosts. It's integral to our commitment to our Host community - who respect their neighbors and want no part of the property damage and other issues that may come with unauthorized or disruptive parties. To that end, today we're announcing the introduction of new anti-party tools in the US and Canada to help identify potentially high-risk reservations and prevent those users from taking advantage of our platform. For example, this system looks at factors like history of positive reviews, length of time the guest has been on Airbnb, length of the trip, distance to the listing, weekend vs. weekday, among many others. The primary objective is attempting to reduce the ability of bad actors to throw unauthorized parties which negatively impact our Hosts, neighbors, and the communities we serve." Reference Link

11:03 EDT Gilead collaborates with Morehouse School of Medicine, Xavier University - Gilead Sciences announced a new health equity collaboration with the Satcher Health Leadership Institute at Morehouse School of Medicine and the Center for Minority Health and Health Disparities Research and Education at Xavier University of Louisiana's College of Pharmacy. The collaboration is focused on addressing the inequities in HIV care for Black communities in the Southern United States. Gilead has a broad and long-standing commitment to advancing global health equity, which it regards as critical to helping to end the HIV epidemic and improving health outcomes for all. The company's health equity strategy focuses on collaborating with organizations that reach underrepresented and disproportionately impacted communities. Research shows that inequities drive higher rates of HIV infection, as well as worse HIV clinical outcomes among Black Americans. The COVID-19 pandemic has further highlighted and exacerbated such health inequities, especially in the Southern United States. SHLI and CMHDRE are at the forefront of efforts to improve access to HIV care for Black communities in the Southern U.S. region. Gilead will award a total of $4.5 million in funding over a three-year period to support their work in three cities: Atlanta, Baton Rouge, La., and New Orleans. The partnership between SHLI and CMHDRE, with support from Gilead, is intended to close critical gaps in care by: Increasing understanding of the impact of COVID-19 on the healthcare delivery system in the Black community; Realigning HIV services to reflect the impact of the COVID-19 pandemic; Providing training focused on culturally appropriate HIV care, inclusive of stigma-reducing strategies; Increasing access to, and utilization of, culturally appropriate care for Black people impacted by the HIV epidemic.

10:24 EDT Asure Software enters agreement to be preferred provider for PrismHR - Asure Software announced it has entered an agreement to be a preferred provider of payroll tax filing software and services for PrismHR. The agreement includes integration between Asure's FlexTax payroll tax filing engine and PrismHR's payroll system, currently in use by more than 80,000 organizations. It also provides PrismHR customers access to Asure's Payroll Tax Management Services, a flexible suite of options that enable customers to outsource payroll tax filing according to their needs and budget, with the ability to scale and adapt to other service plans as their needs change-without changing platforms.

10:21 EDT Waterdrop opens first agency outlet in Wuhan - Waterdrop recently opened its first agency outlet in Wuhan. It will provide local residents with a range of specialized insurance services, such as insurance customization, security risk assessment, policy consulting, and entrusted policy management.

10:07 EDT Air Canada reports 'substantial reduction' in volume of flight cancellations - Air Canada provided the following update on its operational improvement initiatives implemented in response to the challenges the global airline industry has encountered emerging from the pandemic. For the period June 27 to August 14, during which it carried approximately 6.4M customers, the Air Canada family recorded the following operational improvements as it returns to its pre-pandemic customer service levels:Flight Delays - Comparing the week of June 27 to the week of August 8, there was a 48% reduction or 1,160 fewer flights that took a delay longer than one hour. In addition, flight delays overall are getting shorter. For flights that experienced any delay, the average arrival delay during the week of June 27 was 28 minutes longer than the same week in 2019. As of the week of August 8, this had improved to 12 minutes. Flight Cancellations - There has been a substantial reduction in the volume of flight cancellations. During the week of August 8, there was a 77% reduction in the number of cancelled flights as compared to the week of June 27. This translates into 960 fewer flights cancelled. Furthermore, flight completion, which is the percentage of all scheduled flights that are not canceled, reached 96.7% during the week of August 8, which was less than one percentage point lower than the same week in 2019. The vast majority of customers experiencing cancellations, often due to weather or other unexpected factors, were able to travel within 24 hours. Baggage Handling - The strongest area of improvement over this period can be seen in baggage handling, where the airline handles over 650,000 bags per week. During the week of June 27, mishandling rates per 1,000 customers were approximately 2.5 times the same number in 2019. As of the week of August 8, this rate has fully recovered to 2019 levels with a baggage handling success rate of 98%.

10:03 EDT Pure Sunfarms extends partnership with Simon Fraser University - Pure Sunfarms is extending its partnership with Simon Fraser University to advance cannabis plant health research over the next three years. As part of the partnership, SFU researchers and students have access to Pure Sunfarms on-site laboratory and 65,000-square-foot processing center to research ways to mitigate threats to cannabis plant health. Teams use a variety of methods to follow the complete life cycle of plants, looking at environmental conditions, strains and production practices to address and promote the quality of post-harvest cannabis.

10:01 EDT BAE Systems awarded $17.5M contract from DARPA - The Defense Advanced Research Projects Agency has awarded BAE Systems' FAST Labs research and development organization a $17.5M contract for the Generating RF with Photonic Oscillators for Low Noise program. The breakthrough technology developed through the program could enable an unprecedented combination of low noise, compact size, and frequency agility for next-generation airborne sensing and communications capabilities.

10:00 EDT Blend Labs falls -8.9% - Blend Labs is down -8.9%, or -32c to $3.23.

10:00 EDT Agilent rises 7.8% - Agilent is up 7.8%, or $10.42 to $143.19.

10:00 EDT Revlon rises 12.6% - Revlon is up 12.6%, or $1.07 to $9.56.

09:58 EDT Bed Bath & Beyond trading halted, volatility trading pause

09:47 EDT Velo3D falls -8.2% - Velo3D is down -8.2%, or -46c to $5.13.

09:47 EDT ZIM Integrated falls -8.5% - ZIM Integrated is down -8.5%, or -$4.34 to $46.56.

09:47 EDT AMTD Digital rises 9.9% - AMTD Digital is up 9.9%, or $17.98 to $199.00.

09:30 EDT Endo files Chapter 11 bankruptcy, enters agreement with debt holders - Endo International announced that it has entered into a restructuring support agreement with holders of more than a majority of Endo's first lien debt on a sale transaction that would reduce "outstanding indebtedness, address remaining opioid and other litigation-related claims, and best position Endo for the future." Under the RSA, the debtholder group has committed to providing total purchase consideration of approximately $6B in the form of a credit bid, plus assumption of certain liabilities, for substantially all of the company's assets. The transaction contemplates that the purchaser will: Offer employment to all of Endo's active team members; Establish voluntary trusts, to be funded with $550M over 10 years, whereby future proceeds will be set aside for certain opioid claims; and have net funded leverage in an amount no greater than 4.5 times. This "stalking horse" bid will be subject to higher or otherwise better offers, the company said in a statement. To facilitate the sale process and provide an appropriate forum for bringing closure to opioid-related and other uncertainties, Endo and certain of its subsidiaries initiated voluntary prearranged Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of New York. Endo's India-based entities are not part of the Chapter 11 proceedings. The company expects to file recognition proceedings in Canada, the United Kingdom, and Australia. Shares of Endo are up 15% to 43c in premarket trading.

09:28 EDT Diana Shipping announces sale, leaseback of m/v New Orleans, m/v Santa Barbara - Diana Shipping announced that, through two separate wholly-owned subsidiaries, it has entered into two sale and leaseback agreements with two unaffiliated Japanese third parties for the 2015-built Capesize dry bulk vessel, m/v New Orleans, and the 2015-built Capesize dry bulk vessel, m/v Santa Barbara. Upon completion of the transactions, which are estimated to take place by the end of the third quarter of 2022, the Company's gross proceeds will be $66.4M. As part of the agreements, the Company will bareboat charter-in the vessels for a period of eight years and have purchase options beginning at the end of the third year of their bareboat charter period.

09:24 EDT Midnight Theatre sets official opening date in September - Midnight Theatre, the anticipated new variety theater in midtown Manhattan, will officially open the doors to its space on September 21, 2022. This performance venue is located in the heart of New York's Manhattan West, Brookfield Properties' latest neighborhood development between 9th and 10th Avenues and West 31st and 33rd streets. The 160-seat theater was conceptualized by Creative Director Warren Adcock to be a unique home setting for talent in all genres of music, magic, theater and performance art, and will become the home of Mastercard's multisensory studio. Dolphin Entertainment has an ownership position in the Midnight Theatre. Dolphin manages all aspects of publicity and marketing for the venue, as well as facilitates talent and commercial relationships within the entertainment and culinary industries.

09:20 EDT Cuentas reports 'record' digital e-commerce sales in Q2 report - Cuentas announced its Q2 earnings report filed Aug 15, 2022. The report marks the largest growth in e-commerce digital revenue for Q1 & Q2 combined, compared to the same 6 month period in FY2021. This follows its purchase of 19.9% of Cuentas SDI LLC, owner of SDI Black011 assets, to diversify prepaid offerings to Cuentas users. "Thanks to the tireless work of our team and, of course, the growing demand for our product, I'm proud to share that Cuentas has had significant revenue growth," says Arik Maimon, founder and Executive Chairman at Cuentas. "With more key partnerships on the way, we do expect revenues to continue on this upward trend while cost-cutting efforts will help decrease the operating expenses. We are more than optimistic about the future."

09:16 EDT Lowe's says Pro sales remained strong in Q2 - Says Pro customer is "busier than ever." Says DIY sales lower than expected in Q2 and 1H22. Says DIY customer "remains resilient." Says not seeing material indications of trade down in purchases, and instead, seeing the opposite. Comments taken from Q2 earnings conference call.

09:12 EDT Advent Technologies announces delivery of fuel cell products - Advent Technologies announced the successful delivery of Advent's portable fuel cell products to the Hellenic Army's Z Amphibious Raider Squadron, or Z'MAK.

09:10 EDT Apple Hospitality REIT increases dividend to 7c per share from 5c - Apple Hospitality REIT announced that its Board of Directors authorized an increase in the Company's regular monthly cash distributions to 7c per common share, up from 5c per common share, and declared a monthly cash distribution of 7c per common share for the month of September . The distribution is payable on September 15 to shareholders of record as of September 2. Based on the Company's common stock closing price of $17.26 on August 16 the new annualized distribution of 84c per common share represents an annual yield of approximately 4.9%.

09:10 EDT NanoDx, SkyWater Technology announce nano biosensor - NanoDx and SkyWater Technology announced the first commercially ready nano biosensor to yield a protein response. The unique size and electrical properties of nanosensors allow detection of biomarkers and infections never before possible in a simple, portable, point-of-care system. This milestone enables NanoDx to prepare and submit the product for FDA review and eventual commercialization.

09:08 EDT General Motors partners with American Rheinmetall Vehicles in Army truck program - General Motors' wholly-owned subsidiary GM Defense has formed a strategic collaboration with American Rheinmetall Vehicles, a developer of tactical wheeled and tracked combat vehicles and systems, to compete in the U.S. Army's Common Tactical Truck program. The CTT program seeks to identify a replacement platform for the Army's Family of Heavy Tactical Vehicles. American Rheinmetall Vehicles and GM Defense are offering the U.S. Army the HX3-CTT, a derivative of the HX3, in response to the first phase of the Army's Common Tactical Truck program. The Army expects to execute multiple Prototype Projects before determining whether to proceed to initial production that could entail purchase of approximately 5,700 vehicles at a value of around $5B. A Request for Prototype Proposals for the first phase was issued in late June with an expected Contract Award in December. Rheinmetall specializes in tactical military truck development and manufacturing.

09:07 EDT California Water announces BVRT subsidiary enters water supply agreement - California Water Service announced that Camino Real Utility, a wholly owned subsidiary of BVRT Utility Holding Company, BVRT, has entered into a long-term water supply agreement with the Guadalupe Blanco River Authority, GBRA, a water conservation and reclamation district established by the Texas Legislature that oversees water resources for 10 counties. Under the terms of the agreement with GBRA, Camino Real will receive up to 2,419 acre-feet of potable water annually. The GBRA agreement involves four off-takers, including Camino Real, and GBRA plans to extend a potable water pipeline from the City of Lockhart to the City of Mustang Ridge and surrounding areas. Camino Real will be the utility service provider in this fast-growing area of the Austin metropolitan region and will provide potable water, recycled water, and wastewater services to portions of the City of Mustang Ridge and surrounding areas. GBRA plans to extend a water supply pipeline from Lockhart, Texas, into the Mustang Ridge area. Camino Real will invest over $40 million in capital in the first phase of the water supply pipeline project as one of four off-takers.

09:07 EDT ADM and New Culture in strategic pact to scale up alternative dairy products - ADM and New Culture have formed a strategic partnership to accelerate the development and commercialization of alternative dairy products. The partnership highlights both companies' deep commitments to enabling a more sustainable food future...The partnership will enable joint product development, taking advantage of New Culture's innovations in novel ingredients and animal-free dairy products. The companies will work toward accelerating New Culture's food service and consumer applications with the support of ADM's broad portfolio of product development resources and capabilities. New Culture will also have access to ADM's full pantry of sustainable and plant-based ingredients and flavors as New Culture expands the use of animal-free casein into a wide range of animal-free dairy applications. The partnership will also include collaborations to advance the commercial scale-up of New Culture's animal-free casein and dairy products. ADM's global manufacturing assets and expertise will accelerate New Culture's efforts toward commercializing their animal-free mozzarella in the U.S. food service market, beginning with pizzerias in 2023.""This partnership between New Culture and ADM gives our team the chance to accelerate our path to commercialization and expand what's possible for our product portfolio. Leading the transition to an animal-free dairy future requires partners every step of the way and we're thrilled to have a committed partner in ADM, a global leader with deep expertise, reach, and capabilities," said Matt Gibson, co-founder and CEO of New Culture. About New Culture

09:05 EDT Entergy CEO Leo Denault to retire in 2023, CFO Andrew Marsh to succeed - Entergy Chairman and CEO Leo Denault will retire in 2023. As part of a planned leadership succession process, the Entergy board of directors elected Executive Vice President and CFO Andrew Marsh to succeed Denault as CEO, effective Nov. 1. Denault will continue to lead the board as executive chairman until his retirement. Leo Denault was appointed chairman and CEO in 2013. Andrew Marsh joined Entergy in 1998 and served in a series of financial planning and strategy roles, including vice president, planning and financial communications. He was named executive VP and CFO in 2013. Kimberly Fontan, who has served as Senior VP and Chief Accounting Officer since 2019, will succeed Marsh as Executive VP and CFO. Prior to her current role, she served as Vice President, System Planning; Vice President, Regulatory Services; and Vice President, Regulatory Affairs. Fontan joined Entergy in 1996 as a staff accountant. These leadership appointments will be effective Nov. 1.

09:04 EDT Arcimoto announces grand opening of Arcimoto Honolulu - Arcimoto announced that the grand opening of Arcimoto Honolulu, the company's first experience center in Hawai'i, will take place on Saturday, August 20, with rentals officially available on Sunday, August 21. "Hawai'i is absolutely ideal for experiencing Arcimoto vehicles, and we can't wait for locals and tourists alike to experience our pure-electric rides unlike anything else on the road today," said Lynn Yeager, Arcimoto Chief Experience Officer. "I would like to say mahalo to the people of Honolulu who have been so welcoming and supportive of our mission, and to our fans who have waited years to drive an FUV in Hawai'i. At long last, the wait is over."

09:03 EDT Vera Bradley announces World of Vera Bradley via Discord, Twitter - Vera Bradley announced the World of Vera Bradley via Discord and Twitter. This new digital concept will take customers on a journey into the metaverse, bringing together the brand's past, present, and future through its upcoming NFT collections. Vera Bradley now aims to create an experience that bridges the physical and digital worlds and provides a space for women to explore and learn about Web3 through the World of Vera Bradley. Easy to access through worldofverabradley.com, the World of Vera Bradley will also be the point-of-purchase for Vera Bradley's NFT collections, the first of which is slated to launch in September during New York Fashion Week. Aptly named the Heritage Pass, Vera Bradley's genesis NFT will celebrate the brand's 40th anniversary and feature one animated image of Vera Bradley's coveted throwback Jilly Bag in four archived prints. Available for purchase on September 14, 2022, and priced to sell at $82.00, each of the 440 Heritage Pass NFT tokens will function as a Mint Pass and come with a physical, limited-edition Jilly Bag in one of the four heritage prints featured in the NFT. Anticipation of the unknown will add to the excitement of the Heritage Pass, as buyers will receive a Jilly Bag in one of four surprise patterns. Additionally, first-adopters will be rewarded with early access to purchase the second Vera Bradley NFT, launching in October. Available for presale on October 1 and 2 and for public sale on October 3, 2022, Vera Bradley's second NFT drop, the 1982 Collection, will be comprised of 1,982 generative backgrounds derived from 40 archived prints to commemorate the year the company was founded. Priced at $19.82, the 1982 Collection will attract both crypto lovers and breast cancer awareness supporters alike with 100% of Vera Bradley's primary net proceeds benefiting the Vera Bradley Foundation for Breast Cancer, focusing its unique utility on advocacy and fundraising.

08:51 EDT Matthews acquires OLBRICH, R+S Automotive for EUR 43M - Matthews International announced that the Company has closed on the previously-announced acquisitions of German based engineering firms, OLBRICH and R+S Automotive, for EUR 43M. The company said, "Headquartered in Bocholt, Germany, OLBRICH is a production and intelligent equipment manufacturer, specializing in purpose-built rotary processing equipment, including equipment used in the manufacturing of dry and wet electrodes for lithium-ion batteries uses in electric vehicles and components for hydrogen fuel cells and electrolyzers, with additional strong positions in Specialty & Pharma, Packaging and Home & Decor. R+S Automotive is a specialty engineering services provider of automation, plant and tooling concepts for automotive manufacturing companies around the world. The Company plans to integrate OLBRICH and R+S Automotive with its Saueressig Engineering and Energy business, part of its Industrial Technologies segment focused on high-precision engineering for a broad range of industrial automation applications including high-tech custom energy solutions, surfaces, marking, and coding systems."

08:50 EDT Target sees Q3 operating margin rate lower 'well below' previous years - Sees Q4 operating margin rate "much more in line with our recent Q4 experience."

08:44 EDT Target taking 'cautious' stance on share repurchase activity for rest of year

08:43 EDT Cyren Inbox Security achieves SOC 2 Type 2 compliance - Cyren announced it has completed the external audit of its security controls and processes according to the Service Organization Controls 2 Type 2. The process requires an accredited third party to thoroughly review and approve of Cyren's security program over time, giving customers peace of mind that Cyren Inbox Security is operated according to best practices.

08:42 EDT SRM Entertainment enter licensing agreement with Toonz Media Group, Zoonicorn - Jupiter Wellness announced that its SRM Entertainment division has entered into a multi-year global licensing agreement with Los Angeles-based Zoonicorn, the multiplatform animated preschool brand from Zoonicorn, LLC and Toonz Media Group. SRM Entertainment has entered into an agreement to use Zoonicorn with its proprietary Sip With Me children's cup line of products. SRM will develop a full line of Sip With Me Cups for the Zoonicorn franchise. The Sip With Me Zoonicorn line is expected to launch at retailers in the Spring of 2023.

08:37 EDT American Noble Gas commences natural gas, helium sales from Hugoton Field - American Noble Gas announced that helium and natural gas sales have begun from its initial exploratory well relative to AMGAS's participation in its previously announced farm-out agreement to develop oil and gas and brine interests in the Hugoton Gas Field in Haskell and Finney Counties Kansas. The initial well was successfully connected to the gathering system, on August 11, 2022, which marked the beginning of the flow of natural gas and helium for commercial sales. The success of our initial well under our exploration program may indicate the discovery of remaining reserves within the Hugoton Gas Field, which could reinvigorate the Hugoton Gas Field, the largest conventional onshore natural gas and helium field in North America. The initial well in which AMGAS has acquired a 40% participation together with three other venture partners is producing from a single zone and, as previously disclosed, may indicate the existence of remaining gas resources not fully understood before. The initial flow rate ranged from 150 - 185 Mcfpd with initial shut-in pressure of 85 PSIA. This initial production flow and pressure data is very encouraging especially when compared to other wells in the area. For perspective, nearby wells typically have shut-in pressure of less than 15 PSIA. The initial well is flowing at pressures of approximately 8 times the flowing pressure of offset wells. AMGAS is working with its Hugoton Farm-out Venture partners to analyze the information obtained from the successful initial exploratory well drilling and completion to determine the timing and location of the drilling of its next exploratory well. The Farmout Agreement covers drilling and completion of up to 50 wells, including the first exploratory well drilled and completed in August 2022. The Hugoton JV utilizes existing infrastructure assets, including water disposal, existing brine stream, gas gathering and helium processing, as part of the Farmout Agreement. The Farmout Agreement provides the JV with rights to take in-kind, and market its share of helium. Hugoton JV will be able to market and sell the helium produced, at prevailing market prices, by taking its helium in-kind.

08:35 EDT IAA announces new branch located in West Palm Beach, Florida - IAA announces a new branch located in West Palm Beach, Florida, bringing the total number of locations in the state to eleven and three in the market. The branch will provide increased coverage in South Florida and will assist in meeting the growing customer demand in the region. "This state-of-the-art branch in West Palm Beach will help IAA increase capacity and meet the needs of our growing customer base in southeast Florida," said Tim O'Day, President of U.S. Operations. "This conveniently located branch will improve the overall experience for both buyers and sellers."

08:33 EDT Sportradar says CFO leaving company to accept another position in U.S. - Carsten Koerl, CEO of Sportradar, said along with the company's report of results for its second quarter: "Separately, our Chief Financial Officer, Alex Gersh, has decided that he will be leaving the company to accept another position in the United States where he will move with his family. I appreciate Alex's many contributions to Sportradar and invite you to join me in wishing him well as he embarks on his next chapter. We have launched a search for a new CFO, and have named Ulrich Harmuth as interim CFO. Ulrich, who has been with the company since 2013, has served as Chief Strategy Officer since 2020 and has been a member of my management team overseeing corporate development activities, including M&A, strategic partnerships, and ventures. I am confident in Ulrich's leadership to support Sportradar's growth and the continued execution of our financial priorities."

08:32 EDT Edwards Lifesciences' transcatheter repair system granted CE Mark - Edwards Lifesciences' PASCAL Precision transcatheter valve repair system received CE Mark for the treatment of mitral and tricuspid regurgitation. The PASCAL Precision system is utilized in the treatment of patients with mitral or tricuspid regurgitation, through a single delivery system. The new system is designed to enable precise navigation and implant delivery.

08:30 EDT Target COO: Majority of CapEx going into store investment

08:27 EDT Target's fall inventory peak will be lower than spring, says COO

08:25 EDT Bed Bath & Beyond up another 33% in pre-market trading above $27 per share - Shares of Bed Bath & Beyond are up another 33% at $27.43 per share in pre-market trading following yesterday's gains of 29%. The stock is now the highest trending name on StockTwits in terms of message volume over the past 24 hours.

08:21 EDT Tritium and Enel X Way partner for EV charging solutions - Tritium and Enel X Way, the Enel Group's global business line that offers smart EV charging solutions and services, signed a global framework agreement and first contract in the US, deepening Enel X Way's access to Tritium's fast charging hardware and software. Enel X Way will pair its JuiceNet software platform with Tritium's 175kW fast charger and a 50kW variant of the company's RTM to deliver smart fast charging solutions for fleets, automakers, utilities, and public charging sites along highways. The more than 250 fast chargers are expected to qualify for a tax credit that was recently modified and extended as part of the Inflation Reduction Act. Under the Alternative Fuel Vehicle Refueling Property Credit, commercial projects now qualify for a maximum incentive of 30% or $100K per charger, up from $30K per property, whichever is of lesser value. In the future, the companies intend to further expand their relationship to meet the National Electric Vehicle Infrastructure Formula Program objectives, which will support the Biden-Harris Administration's goal to develop a national network of 500,000 EV chargers. Tritium's PKM150 and RTM are expected to begin US production at the company's Tennessee factory this fall and meet the Federal Highway Administration's Buy America compliance requirement in 1Q23. The companies plan to sign additional regional contracts to further expand access to fast charging around the world.

08:21 EDT Equitable Holdings acquires Penn Investment Advisors - Equitable announced the acquisition of Penn Investment Advisors, PIA , a registered investment adviser and subsidiary of Penn Community Bank. The acquisition is expected to close in the fourth quarter of 2022. Headquartered in Bucks County, Pa., Penn Investment Advisors has $600M in assets under administration and serves 950 clients. This announcement advances Equitable's strategy to grow its wealth management business, Equitable Advisors , which has $70.8B in assets under administration as of 6/30/22 and 4,200 financial professionals.

08:14 EDT Qorvo introduces QPD1034 RF GaN-on-SiC Pallet Solution - Qorvo introduced the QPD1034, a 1700 watt high power RF Gallium Nitride pallet that supports Tactical Air Navigation and Distance Measuring Equipment applications for air traffic control.The QPD1034 allows instantaneous 960 to 1,215 MHz operation and is an integrated and compact GaN-on-SiC pallet amplifier solution fully matched to 50 Ohms and features 16dB of gain and 62% drain efficiency.

08:12 EDT Camac 'condemns' Forte Biosciences for highly dilutive equity capital raise - Camac Partners, which is one of the largest shareholders of Forte Biosciences "expressed concerns regarding the Company's sizable trading price discount relative to its cash on hand and the Board of Directors' decision to conduct a highly dilutive equity capital raise following the emergence of four separate Schedule 13D filers," said the statement. Eric Shahinian, founder and managing member of Camac, commented: "Since Forte's initial public offering, the Company's share price has declined approximately 95%. We believe shareholders have lost all confidence in Forte due to the Board and management's failure to establish a sensible capital allocation strategy, as well as inexcusable lapses in governance. We understand why the Company now trades at an approximately 40% percent discount to its roughly $45 million in cash. To make matters worse, following the emergence of four separate 13D filers that independently possess significant concerns, the Board has conducted a dilutive capital raise at a massive discount to cash that we view as defensive and without a justifiable business purpose. Rather than take such a brazen step that permanently impairs investors, the Board should consider how to return capital to the Company's long-suffering shareholders."

08:11 EDT TransUnion announces collaboration with Canvas Worldwide - TransUnion announced a collaboration with Canvas Worldwide, the world's second-largest independent media agency. This collaboration will enable Canvas clients to tap into TransUnion's robust view of consumers, anchored in offline data, machine learning and automation. As a result, it will simplify and drive smarter audience planning, enable custom audience creation and optimize measurement for some of the world's premier advertisers. The new partnership opens the door to bring more data-driven advertiser solutions leveraging advanced lookalike modeling, custom audience creation and omnichannel activation to the market. The combined force of TransUnion and Canvas improves the precision and quantity of the data suite Canvas clients can tap into, delivering a new, closed-loop audience management capability, allowing for more sophisticated data analysis and powerful audience insights.

08:10 EDT Moderna appoints James Mock as CFO - Moderna (MRNA) announced that James Mock has been appointed as Moderna's CFO, beginning September 6. He will serve on Moderna's executive committee and report to CEO Stephane Bancel. Following the appointment of Mock, David Meline will retire as the company's CFO effective the same date but will remain as a consultant to the company to assist with the transition. Prior to joining the company, Mock served as senior VP and CFO of PerkinElmer (PKI) a life sciences, diagnostics and analytical solutions company, since May 2018.

08:09 EDT Laird Superfood says EF Hutton SPV I offered to acquire company for $3 per share

08:08 EDT GreenBox announces restructuring of convertible note terms - GreenBox POS announced that it has entered into an agreement to restructure the terms of the $100M convertible note financing, originally entered into on November 2, 2021. Under the amended agreement, and as detailed on the Company's filed Form 8-K, the note maturity will be extended by one year from November 5, 2023 to November 5, 2024. Additionally, for interest payments due on and after October 3, 2022 unless the Company specifies with written notice that interest will be paid in cash, GreenBox will issue shares of its common stock instead.

08:07 EDT Target added more than 90M customer visits over last 3 years, says CEO

08:07 EDT Grom Social's Top Draw Animation secures $1.3M in assignments - Grom Social Enterprises announced that Top Draw Animation has been awarded an additional $1.3M in animation assignments, that will further bolster the studio's output. Production on the new assignments is anticipated to commence in late Q3-2022.

08:06 EDT Enlivex receives Israeli MOH authorization to start Phase I/II Allocetra study - Enlivex Therapeutics announced that the Israeli Ministry of Health, MOH, authorized the initiation of a company-sponsored Phase I/II clinical trial designed to evaluate the safety, tolerability and preliminary efficacy of Allocetra alone, and in combination with a PD1 checkpoint inhibitor, in patients with advanced solid tumors. Einat Galamidi, M.D., Vice President, Medical of Enlivex, stated, "With Allocetra treatment, we aim to change the balance of macrophage populations surrounding the solid tumor environment in favor of anti-cancer activity in order to overcome the biological mechanisms underlying checkpoint inhibitor resistance. Collaborative studies with Yale Cancer Center have generated meaningful preclinical data, suggesting we may be successful in these efforts, with Allocetra and an anti-PD1 agent synergistically combining, which delivered a statistically significant survival benefit in a murine model of ovarian cancer. We aim to build on these results in our upcoming Phase I/II trial and are pleased that the Israeli Ministry of Health has cleared it for initiation." The planned Phase I/II trial is a multicenter, open-label, dose escalation trial that is expected to enroll up to 48 patients with advanced solid tumors across two trial stages. The primary objective of the study is to evaluate safety and tolerability throughout the treatment period and through one week after the last administration of Allocetra. Key secondary endpoints include efficacy assessments, such as best overall response rate, progression-free survival, and overall survival.

08:04 EDT Oyster Point Pharma announces TYRVAYA coveragy by Medicare PBM - Oyster Point Pharma announced that the largest Medicare Pharmacy Benefit Manager in the United States will add TYRVAYA Nasal Spray on its Medicare Part D formularies, effective September 1, 2022.

08:04 EDT SAIC awarded $319M Air Force contract - SAIC has been awarded the $319M Falconer Air Operations Center, or AOC, Weapon System Sustainment contract by the U.S. Air Force. The SAIC team will partner with Kessel Run, a Division within the Air Force Life Cycle Management Center's, or AFLCMC, Digital Directorate, to provide Air Operations Centers around the globe with a reliable, secure and modernized mission system to plan and conduct air operations. The Falconer program assists Air Force component commanders in planning, directing and assessing air, space and cyberspace operations. The AOC ingests, analyzes and disseminates command, control and intelligence data to support operations.

08:03 EDT RedHill Biopharma's RHB-204 for NTM infections gets EU orphan drug designation - RedHill Biopharma announced that the European Commission has granted Orphan Drug Designation to RHB-2041 for the treatment of nontuberculous mycobacteria disease, following a positive opinion recommendation by the European Medicines Agency's Committee for Orphan Medicinal Products. The EMA grants Orphan status to treatments of a life-threatening or chronically debilitating condition that is rare. Orphan Designation provides for free protocol assistance, potential reductions in fees, and eligibility for 10 years post-launch market exclusivity. A U.S. Phase 3 study is ongoing to evaluate the efficacy and safety of RHB-204 in adults with pulmonary NTM disease caused by Mycobacterium avium complex - MAC - infection. The company is advancing discussions with prospective partners for RHB-204 across multiple territories.

07:54 EDT DigiMax completes acquisition of Spetz Tech - DIGIMAX GLOBAL announced that further to its press release dated June 23, 2022, the Company has completed its acquisition of 100% of the issued and outstanding securities of Israel-based Spetz Tech, a technology company which has developed artificial intelligence software to operate a mobile application that connects consumers to available, top-rated tradespeople, service providers and professionals in their area immediately or at any scheduled time. The Transaction was completed pursuant to the terms of a merger agreement, dated June 23, 2022. In consideration for all of the issued and outstanding shares of Spetz, DigiMax has issued 250 million securities of the Company to the securityholders of Spetz, which amounts to approximately 47% of the issued and outstanding securities of the Company upon the closing of the Transaction. The number of Consideration Securities being issued to the securityholders of Spetz is not contingent on the trading price of DigiMax's common shares on the Canadian Securities Exchange. Upon Closing, Yossi Nevo, the founder and CEO of Spetz, has assumed the role of COO of the Company, and Ofir Friedman, Spetz's VP of Marketing & Business Development, has assumed the role of CMO of the Company. In addition to the foregoing, both Messrs. Nevo and Friedman have been appointed to the Company's board of directors upon Closing. In addition to the foregoing, the Company has issued stock options to certain directors, insiders and employees of the Company to acquire 7,250,000 common shares of the Company exercisable at $0.05 per share for a period of 5 years form the date of grant. Recently issued audited financial statements state that Spetz generated revenues of $2.98 million in calendar year 2021 versus $1.36 million in 2020 having realized 219% growth year over year. This resulted in comprehensive losses of $2.13 million and $1.34 million respectively for 2021 and 2020. Losses as a percent of revenue declined by 27.7% over the two years. In connection with the Transaction, the Company and Spetz have agreed to pay a finder's fee to a certain arm's length party. The Finder's Fee is comprised of 4 million common shares of the Company.

07:48 EDT Newcrest Mining withdraws option, farm-in agreement for Miocene Project - Cornerstone Capital Resources announces that Newcrest International has notified Cornerstone and its subsidiary Mineral Cornerstone Chile Limitada that Newcrest intends to withdraw from the option and farm-in Agreement on MCCL's Miocene concessions in Chile targeting epithermal gold-silver and porphyry gold-copper deposits along the interpreted northern extension of the Maricunga magmatic belt that hosts several world-class gold deposits. President and CEO Brooke Macdonald said: "Newcrest is one of the largest gold mining companies in the world, operating mines in Australia, Papua New Guinea, and Canada. They spent over $2.6M on the Project, in excess of their $1.1M work commitment, and have been an excellent partner. As reported in Cornerstone's news release 22-11 dated April 28, 2022, after drilling three reverse circulation holes no significant assays were reported. As per the terms of our Agreement, Newcrest will wind down activities and leave the concessions in good standing for one year, while Cornerstone determines if we can attract another funding partner to reactivate the Project."

07:40 EDT Sachem Capital announces registered public offering of notes - Sachem Capital announced the commencement of a registered public offering of unsecured, unsubordinated notes due five years from the date of issuance. The Notes will rank pari passu with all the company's unsecured, unsubordinated indebtedness, whether currently outstanding or issued in the future. The Notes are expected to be listed on the NYSE American under the trading symbol "SCCG" and to trade thereon within 30 days of the original issue date. The interest rate and other terms of the Notes will be determined at the time of the pricing of the offering. The Notes have a private credit rating of BBB+ from Egan-Jones Ratings Company, an independent, unaffiliated rating agency. Egan-Jones is a Nationally Recognized Statistical Ratings Organizationand is recognized by the National Association of Insurance Commissioners as a Credit Rating Provider. Egan-Jones is also certified by the European Securities and Markets Authority. A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

07:38 EDT Newmont names Peter Toth as Chief Strategy and Sustainability Officer - Newmont has announced Peter Toth as Chief Strategy and Sustainability Officer following the retirement of Chief Sustainability & External Affairs Officer Stephen Gottesfeld after 25 years of dedicated service to the Company. Newmont has long been a leader in sustainable and responsible mining, and considers environmental, social and governance practices to be fundamental to the way in which it operates. With the appointment of Peter Toth, the Company will further incorporate these critical elements into its future strategy. In October 2021, Newmont announced that Peter Toth, a 25-year veteran of the industry, would join the Company as Executive Vice President, Strategic Development. Peter has extensive experience with integrating sustainability practices into broader corporate strategies, having led the development of Rio Tinto's 10-year climate strategy in support of their ambition of reaching net zero by 2050.

07:34 EDT Stock Yards Bancorp increases quarterly dividend to 29c per share - Stock Yards Bancorp announced that its Board of Directors increased its cash dividend to 29c per common share. The dividend will be paid on October 3, 2022, to stockholders of record as of September 19, 2022. Commenting on the announcement, James Hillebrand, Chairman and Chief Executive Officer, said, "With the strength of our earnings and solid capital position, we are pleased to increase our cash dividend rate as part of our continued efforts to provide returns to our loyal shareholders. With this announcement, Stock Yards Bancorp has now raised its quarterly dividend rate a total of 15 times since 2012, resulting in a cumulative increase of 118% over that time. The increased dividend highlights our Company's stellar performance throughout the past year and the attractive growth opportunities we see ahead."

07:33 EDT Quest Diagnostics launches test panel to screen hepatitis C in early pregnancy - Quest Diagnostics launched a new obstetrics laboratory test panel designed to enable physicians to screen all eligible pregnant people easily and reliably for hepatitis C with other laboratory tests typically ordered during early pregnancy. The company developed the new test panel to include HCV antibody testing with reflex to quantitative real-time PCR in response to findings from a Quest Diagnostics Health Trends study published in Obstetrics & Gynecology in June which found that less than 41% of pregnant people were screened for HCV in 2021. In recent years, hepatitis C infections have risen in pregnant people and other populations in the U.S., largely due to increased intravenous drug use.

07:32 EDT Aehr Test Systems receives $4M production order for WaferPak - Aehr Test Systems announced it has received over $4M in orders from its lead silicon carbide test and burn-in customer for WaferPak full wafer Contactors for multiple new silicon carbide device designs and increased production capacity needs for power semiconductors for the electric vehicle market. These WaferPak Contactors are expected to ship by the end of Aehr's fiscal third quarter ending February 28, 2023. Gayn Erickson, President and CEO of Aehr Test Systems, commented, "We are excited to receive these orders for additional WaferPak Contactors to meet this customer's increased production capacity needs as well as for multiple new device configurations to be qualified by their customers. These WaferPak Contactor orders are for FOX systems previously ordered by this customer. We also expect them to order multiple new sets of WaferPak Contactors in the future to be used with the new system orders announced last month for current devices that have already been qualified by electric vehicle manufacturers. This customer recently announced that they expect their growth rate to accelerate faster than previously forecasted. They continue to forecast orders for a significant number of FOX systems and WaferPak Contactors over the next several years and into the future, driven by semiconductor demand for the electric vehicle market that is expected to grow at least 30 percent plus annually over the next decade. Multiple companies including this lead silicon carbide customer have announced their plans to significantly increase their output capacity, which is exciting for our business. Aehr has been increasing manufacturing capacity of both our systems and WaferPak Contactors to meet the anticipated capacity needs of the silicon carbide market this year and through the end of the decade.

07:23 EDT Northern Oil and Gas in pact to buy Midland Basin properties for $110M - NOG has entered into a definitive agreement to acquire non-operated interests in the Midland Basin for a purchase price of $110M in cash, subject to typical closing adjustments. NOG expects to fund the acquisition with cash on hand, operating free cash flow and borrowings under NOG's revolving credit facility. At closing, production on the assets is expected to be greater than 1,600 Boe per day and NOG expects average production of over 1,800 Boe per day over the next twelve months post-closing . NOG expects less than $5 million of capital expenditures to be incurred post-closing in 2022 and does not anticipate revising 2022 capital expenditure guidance for the acquisition. These high-quality properties have operating costs lower than NOG's corporate average. The acquired assets are located in Howard County, Texas and include approximately 1,600 acres, 6.4 net producing wells, 1.6 net wells-in-process and approximately 8 net undeveloped locations. Substantially all of the assets are operated by SM Energy. The effective date for the transaction is August 1, 2022, and NOG expects to close the transaction in October 2022. The obligations of the parties to complete the transactions contemplated by the purchase agreement are subject to the satisfaction or waiver of customary closing conditions.

07:20 EDT Charge Enterprises selected by Connected Kerb for pilot project - Charge Enterprises announced Connected Kerb has selected Charge Infrastructure as its installation provider for a pilot project in New York City. Charge Enterprises and Connected Kerb will collaborate on this groundbreaking pilot which will focus on testing scalable, cost-effective charging infrastructure in New York City. This project is driven by a collaboration between the New York City Department of Transportation and Newlab, the DOT Studio, which is focused on applying emerging technologies to advance planning, policy, operations, and real-time management of transportation across New York City to support the City's Vision Zero and sustainability goals. One of the objectives of the pilot is to help drive EV charging rollouts across New York City, with the mission of leveraging potential funding opportunities to achieve the City's goal of 10,000 curbside chargers by 2030, and electrifying 20% of municipal parking bays by 2025

07:17 EDT Manitou Gold intends to spin out nickel-cobalt-PGE commodities - Manitou Gold announced that its board of directors has approved, in principle, a strategic reorganization of Manitou's assets pursuant to which Manitou proposes to spin out the nickel-cobalt-PGE commodities from its Goudreau project into a newly incorporated, wholly-owned subsidiary named Western Nickel Corp. The Spin-Out, if completed as presently proposed, would result in, among other things, a listing of the common shares of Western Nickel on a Canadian stock exchange and a portion of the issued and outstanding Western Nickel Shares being distributed directly to the shareholders of Manitou on a pro rata basis. The completion of the Spin-Out will allow Manitou to continue as a gold-focused exploration company. The decision to undertake the Spin-Out was prompted by the Company's recent success in demonstrating, in addition to the Goudreau project's high level of prospectivity for an economic gold deposit, the broad untested potential for significant nickel mineralization within the Goudreau project. It is the view of both management and the board of Manitou that the Spin-Out is the most effective way to unlock the value of the Goudreau project that relates to its Ni-Co-PGE potential. The Company also announces the immediate commencement of a 1,000 metre drill program as a direct follow-up to the recent drill intersection of 0.25% Ni over 48 metres at its 100% owned Goudreau project in northeastern Ontario. It is anticipated that the results of this program will provide additional intersections of the nickel bearing ultramafic units. The Spin-Out of nickel-cobalt-PGE commodities remains subject to Manitou's management and Board continued consideration and discretion. It is currently anticipated that the Spin-Out will be effected by way of plan of arrangement, and Manitou will retain up to 19.9% of the Western Nickel Shares issued and outstanding at closing. However, the final terms of the Spin-Out and determination to proceed remain subject to further tax and securities considerations, and the Company expects to provide a further update to shareholders over the ensuing fiscal quarter. Recent results from the Company's first drill program at the western extension of the Baltimore deformation zone demonstrate the untested potential for significant nickel mineralization, comparable to Canada Nickel Company's Crawford deposit, located in Timmins, and the Dumont nickel deposit, located in Quebec. As reported on June 13 2022, Manitou intersected a 48 m wide interval of highly serpentinized ultramafic rocks grading 0.25% Ni and 100 ppm Co starting at 29.0 m after reaching bedrock. The hole was collared in nickel mineralization near the southern margin of the ultramafic intrusion and, therefore, did not intersect the full width of the mineralized zone. Nickel mineralization was in the mineral awaruite, which is a nickel dominant iron alloy that can occur in serpentinized ultramafic intrusive rocks which are prevalent on the Goudreau project. Completion of the Spin-Out is subject to a number of conditions, including but not limited to, the approval of the TSX Venture Exchange, and if applicable, court and disinterested shareholder approval, as well as other closing conditions and the final approval of the board of directors of the Company. The Spin-Out cannot close until the applicable regulatory, court and shareholder approvals are obtained. There can be no assurance that the Spin-Out will be completed as proposed, or at all. Manitou's key strategic shareholders include Alamos Gold at 19.9% and O3 Mining at 9.9%, each individually calculated on a partially diluted basis.

07:11 EDT Gritstone announces inducement grants under Nasdaq listing rule - Gritstone bio announced that the company's Board of Directors granted eight employees nonqualified stock options to purchase an aggregate of 239,100 shares of its common stock with an exercise price of $3.40, which is equal to the closing price of Gritstone's common stock on August 10, 2022, the date of the grant. These stock options are part of an inducement material to each of the new employees becoming an employee of Gritstone, in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options will vest over a four-year period, with 25% of the options vesting on the first anniversary of the employees' date of hire, and 1/48th of the options vesting monthly thereafter, subject to the employees' continued employment with Gritstone on such vesting dates.

07:10 EDT Meta Materials appoints Jack Harding as Chairman of board, effective August 16 - Meta Materials announced the appointment of Mr. Jack Harding as Chair of the Board of Directors, effective August 16, 2022. Mr. Ram Ramkumar, META's current Chair, is retiring from the Board and moving into a Strategic Advisor role for a period of two years. The Company wishes to thank Mr. Ramkumar for his dedication during this transformative period which included among many milestones META's June 2021 listing on the NASDAQ via a reverse merger with Torchlight Energy Resources. "Delivering innovation at scale is only achievable with the support and guidance of leaders who have successfully done it before," said George Palikaras President & CEO. "I am excited to have Jack Harding join us as Chair as we enter this new growth phase in our journey to become the world's leading metamaterials company. His wealth of experience in the semiconductor industry, and his knowledge of every facet of a high-tech business, will be tremendously beneficial to us. On behalf of META's Board, it is my pleasure to welcome Jack, and we want to thank Ram for all his contributions and look forward to his continued support in his new advisory role."

07:09 EDT Worksport launches all-new e-commerce online platform - Worksport and its subsidiaries announces the launch of its eCommerce platform. Worksport, with its patented truck bed tonneau cover designs aims to provide the EV and ESS industries with renewable energy and solar PV solutions, integrations for the sustainable, and personal clean energy to the automotive, recreational vehicle industries and communities as well as outdoor enthusiasts. The online platform will also be home to the Company's widely anticipated flagship products, SOLIS, the folding truck bed tonneau cover with integrated solar panels and COR, its portable energy storage system with modular batteries and Advanced hot-swap technology. "The new facility, our expanded staff, and eCommerce site are the result of two years' worth of planning. We believe it will permit Worksport to take complete control of its production and sales pipelines for all its current and future products. Parallel eCommerce sites are also available on Wal-Mart, Amazon and eBay, which will help realize revenue sooner rather than later in 2022." Steven Rossi, Chief Executive Officer, Worksport said. Rossi also added "We will be selecting a few pre-ordering customers ahead of the official launch of SOLIS and COR on the Worksport eCommerce site to receive the first production-ready versions of the product prior to its official sale at a discounted price.

07:08 EDT Blueprint Medicines'Ayvakit achieves endpoints in mastocytosis trial - Blueprint Medicines announced positive top-line results from the registrational Part 2 of the PIONEER clinical trial of Ayvakit in patients with non-advanced systemic mastocytosis demonstrating clinically meaningful and highly significant improvements across the primary and all key secondary endpoints, including patient-reported symptoms and objective measures of mast cell burden. Based on these top-line data, Blueprint Medicines plans to submit a supplemental new drug application to the FDA for Ayvakit in non-advanced SM in 4Q22, with a subsequent submission of a type II variation marketing authorization application to the EMA anticipated in 2023. In addition, Blueprint Medicines plans to present detailed data from the trial at an upcoming medical meeting. The trial achieved its primary endpoint with a highly significant difference in the mean change in total symptom score at 24 weeks. TSS was assessed by the Indolent SM Symptom Assessment Form. In addition, the Pioneer trial met all key secondary endpoints, including significant improvements across all measures of mast cell burden. Ayvakit was well-tolerated and had a favorable safety profile.

07:08 EDT Provectus expands sponsored research collaboration with University of Calgary - Provectus announced that the Company has expanded its sponsored research program with Aru Narendran, MD, PhD, Professor, Departments of Pediatrics, Oncology, Biochemistry & Molecular Biology, and Physiology & Pharmacology at the Cumming School of Medicine of the University of Calgary in Calgary, Alberta, Canada to investigate systemic administration of Provectus' pharmaceutical-grade rose bengal for the treatment of pediatric leukemia. The Company's innovatively-assembled and proprietary rose bengal is the lead member of a class of small molecules called halogenated xanthenes. As part of this new sponsored research, the Narendran team plans to: Identify clinically-feasible drug combinations and synthetic lethality that have synergistic activity with Provectus' rose bengal, Evaluate systemic drug administration routes for maximal tolerability, Evaluate the modulation of WNK1 and other related pathways induced by the Company's rose bengal, and Complete demonstration of STING dimerization in leukemia cells. The Narendran team has previously shown: In vitro activity and target modulation effects of Provectus' rose bengal against several different pediatric leukemia-derived cell lines and primary cells, Proof-of-concept of several potential mechanisms that may be involved in this process, Rose bengal's ability to induce STING dimerization and the molecule's association with heat shock proteins, and Preliminary evidence of in vivo activity in mouse xenograft models using the pediatric leukemia cell line SEM following oral doses of the Company's rose bengal.

07:06 EDT CytoSorbents: Israeli Ministry of Health approves reimbursement for CytoSorb - CytoSorbents announced that the Israeli Ministry of Health has approved national reimbursement for CytoSorb in certain cardiac surgery indications that is expected to take effect in 2023. Specifically, the Hospital Technologies Committee of the Israeli MoH has approved national CytoSorb reimbursement, also known as "addition to the Healthcare Basket," for the following indications: Intraoperative treatment for urgent or emergency cardiac surgery in patients treated with ticagrelor or rivaroxaban; Intraoperative treatment during cardiac surgery in patients with acute infective endocarditis; Intraoperative treatment during surgery for correction of aortic dissection. With its decision, the Committee recognizes the importance and value of CytoSorb to remove a variety of antithrombotic drugs and inflammatory mediators intraoperatively during cardiac surgery. Once the policy revision is completed, public hospitals are expected to receive reimbursement for CytoSorb for these applications.

07:03 EDT Children's Place plans to close 40 stores this year - The Company ended the second quarter of 2022 with 658 stores and square footage of 3.1 million, a decrease of 8% compared to the prior year and a decrease of 31% compared to the end of Q2 2019, when the Company operated 961 stores. Consistent with the Company's store fleet optimization initiative, the Company permanently closed 7 stores during the second quarter of 2022 and has permanently closed 541 stores since 2013 and decreased total square footage by 2.1 million square feet or approximately 40%. The Company is planning to close a total of approximately 40 stores this year.

06:20 EDT Entain announces regulatory settlement with British Gambling Commission - Entain announced that it can confirm that it has agreed a regulatory settlement with the British Gambling Commission. The regulatory settlement amounts to GBP 14M in respect of Entain's digital business, and GBP 3M in respect of its retail business. "Entain accepts that certain legacy systems and processes supporting the operations of its British business during 2019 and 2020 were not in line with the evolving regulatory expectations of the Commission in respect to aspects of social responsibility and anti-money laundering safeguards. However the Group also notes the Commission's statement that it found no evidence whatsoever of criminal spend within Entain's operations. The GBP 17M settlement amount was already provided for in the Group's financial statements," the company said.

06:11 EDT Ceragon Networks selected by operator in North America for expansion project - Ceragon Networks announced that an operator in North America selected its equipment, software, rollout, and managed services for a large expansion project. The operator is planning to leverage Ceragon's high-band spectrum assets to enhance its 5G service offering, and selected Ceragon for its technology, proven experience, reliability, and comprehensive solution offering - from design to operations and maintenance. This project will further expand Ceragon's market share in North America. Ceragon has already started receiving equipment orders and expects remaining orders to be completed in 2022. Project rollout is expected to start early 2023.

06:08 EDT Akso Health receives noncompliance notification from Nasdaq - Akso Health announced that the company received a written notification from Nasdaq on August 16, indicating the company is not in compliance with the timely filing requirement for continued listing under Nasdaq Listing Rules 5250 since the company has not yet filed its Annual Report on Form 20-F for the fiscal year ended March 31 with the Securities and Exchange Commission.

06:02 EDT Axonics expands sacral neuromodulation intellectual property portfolio - Axonics has been granted eight patents and allowed four patent applications by the USPTO related to the company's sacral neuromodulation technology in the last twelve months. The patents and allowed applications are part of Axonics' patent portfolio and represents technology internally developed by the company covering a range of subject matter that includes the Axonics external trial system, tined lead, implantable neurostimulator, clinician programmer, wireless charging system and patient remote control.

05:48 EDT Elon Musk tweets he's buying Manchester United, then calls it a joke - Tesla (TSLA) CEO Elon Musk said on Twitter he was buying English soccer team Manchester United (MANU) only to say hours later it was a joke. Musk's initial tweet on Tuesday came as a reply to a post he'd made about politics, in which he said "To be clear, I support the left half of the Republican Party and the right half of the Democratic Party!" Musk then tweeted: "Also, I'm buying Manchester United ur welcome." The Tesla CEO followed up later, responding to a follower asking if he was serious, saying "No, this is a long-running joke on Twitter. I'm not buying any sports teams." Reference Link

05:22 EDT Iterum Therapeutics to effect 1-for-15 reverse share split - Iterum Therapeutics announced that it will effect a 1-for-15 reverse share split of its outstanding ordinary shares at 5.00 p.m. Eastern Time on August 17, which will be effective for trading purposes on Nasdaq as of the commencement of trading on August 18.

05:17 EDT CAE signs 15-year agreement with Qantas Group for new pilot training center - CAE announced that it has signed an exclusive 15-year agreement with the Qantas Group, to develop and operate a new pilot training center in Sydney, Australia. CAE will operate a new 7,000 square-meter CAE Sydney Training Centre that is slated to open in early 2024. In addition, CAE will deploy a new A320 full flight simulator and purchase the Qantas Group's B787, A330, and B737NG full-flight simulators and associated integrated procedures trainers for the new center. The Qantas Group's A380 full-flight simulator and emergency procedures equipment will also be relocated to the new CAE Sydney Training Centre, where they will be operated and maintained by CAE. The development is subject to planning approvals, with a submission lodged by Logos who will develop the center in partnership with CAE and the Qantas Group. With a capacity for up to eight full-flight simulators, the CAE Sydney Training Centre will enable CAE to add more training capacity to address the addition of A350 and A321XLR aircraft to the Qantas Group's fleet. This new center will also allow CAE to grow its network capacity to provide training to operators in the region.

05:07 EDT Elbit Systems awarded two contracts to upgrade MBT for $240M in total - Elbit Systems announced that it was awarded two contracts, in an aggregate amount valued at $240M, to upgrade Main Battle Tanks, or MBT, for an international customer. A $60M contract will be delivered over a period of two years and a $180M contract will be delivered over a period of four years. Under the contracts, Elbit Systems will perform an upgrade of the MBTs and provide advanced electronics suites.